Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | RBS2418 |
Trade Name | |
Synonyms | RBS 2418|RBS-2418 |
Drug Descriptions |
RBS2418 inhibits ENPP1, which results in decreased adenosine levels and potentially results in enhanced antitumor immune response (J Clin Oncol 40, no. 16_suppl (June 01, 2022) e14550). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C187127 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Pembrolizumab + RBS2418 | Pembrolizumab RBS2418 | 0 | 0 |
RBS2418 | RBS2418 | 0 | 1 |